After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate
Oil controls the market, and Cramer is watching stocks to see which you should be buying.
Cramer is no fan of J.C. Penney and says NCR is up too much.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.